Tarbox Family Office’s Cytokinetics CYTK Stock Holding History

Tarbox Family Office’s Portfolio CYTK Stock Details CYTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-126	Closed	-$5K	–	335
2022 Q1	$5K	Hold	126	–	–	﹤0.01%	524
2021 Q4	$6K	Hold	126	–	–	﹤0.01%	549
2021 Q3	$5K	Hold	126	–	–	﹤0.01%	626
2021 Q2	$2K	Hold	126	–	–	﹤0.01%	914
2021 Q1	$3K	Hold	126	–	–	﹤0.01%	738
2020 Q4	$3K	Hold	126	–	–	﹤0.01%	671
2020 Q3	$3K	Hold	126	–	–	﹤0.01%	598
2020 Q2	$3K	Hold	126	–	–	﹤0.01%	604
2020 Q1	$1K	Buy	+126	New	+$1.61K	﹤0.01%	834

Other funds holding CYTK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Tarbox Family Office's CYTK Position: Q2 2022 in Review

Tarbox Family Office sold out of Cytokinetics (CYTK) in Q2 2022, closing a stake of 126 shares — an estimated $5K sold.

Tarbox Family Office first reported a position in CYTK in Q1 2020 and held it in 9 quarters. The position peaked at $6K in Q4 2021. 262 funds tracked by Wall St. Rank hold CYTK as of Q2 2022.

Tarbox Family Office reported no remaining Cytokinetics position as of Q2 2022 after selling out during the quarter.
Tarbox Family Office sold 126 Cytokinetics shares in Q2 2022, an estimated $5K.
Tarbox Family Office first reported a position in Cytokinetics in Q1 2020 and held it in 9 quarters.
Tarbox Family Office's Cytokinetics position peaked at $6K in Q4 2021.
262 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2022.

Based on Tarbox Family Office's 13F filing for Q2 2022, filed 19 Jul 2022.